Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Novel statistical tools for monitoring the safety of marketed drugs.

Almenoff JS, Pattishall EN, Gibbs TG, DuMouchel W, Evans SJ, Yuen N.

Clin Pharmacol Ther. 2007 Aug;82(2):157-66. Epub 2007 May 30. Review.

PMID:
17538548
2.

Safety monitoring of new anti-malarials in immediate post-marketing phase.

Edwards IR.

Med Trop (Mars). 1998;58(3 Suppl):93-6. Review.

PMID:
10212911
3.
4.

Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?

Michel C, Scosyrev E, Petrin M, Schmouder R.

Clin Drug Investig. 2017 May;37(5):415-422. doi: 10.1007/s40261-017-0503-6. Review.

PMID:
28224371
5.

Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?

Trifirò G, Coloma PM, Rijnbeek PR, Romio S, Mosseveld B, Weibel D, Bonhoeffer J, Schuemie M, van der Lei J, Sturkenboom M.

J Intern Med. 2014 Jun;275(6):551-61. doi: 10.1111/joim.12159. Review.

6.

[Safety of medicinal products and reporting of adverse drug reactions].

Skibicka I, Maciejczyk A.

Neurol Neurochir Pol. 2004 Nov-Dec;38(6):503-10. Review. Polish.

PMID:
15654675
7.

Quantitative methods in pharmacovigilance: focus on signal detection.

Hauben M, Zhou X.

Drug Saf. 2003;26(3):159-86. Review.

PMID:
12580646
8.

Perspectives on the use of data mining in pharmaco-vigilance.

Almenoff J, Tonning JM, Gould AL, Szarfman A, Hauben M, Ouellet-Hellstrom R, Ball R, Hornbuckle K, Walsh L, Yee C, Sacks ST, Yuen N, Patadia V, Blum M, Johnston M, Gerrits C, Seifert H, Lacroix K.

Drug Saf. 2005;28(11):981-1007. Review.

PMID:
16231953
9.

Effect of consumer reporting on signal detection: using disproportionality analysis.

Hammond IW, Rich DS, Gibbs TG.

Expert Opin Drug Saf. 2007 Nov;6(6):705-12. Review.

PMID:
17967159
10.

Signal detection methodologies to support effective safety management.

van Manen RP, Fram D, DuMouchel W.

Expert Opin Drug Saf. 2007 Jul;6(4):451-64. Review.

PMID:
17688389
11.

Preventing postmarketing changes in recommended doses and marketing withdrawals.

Peck C.

Ernst Schering Res Found Workshop. 2007;(59):209-16. Review.

PMID:
17117726
12.

Implemented data mining and signal management systems on spontaneous reporting systems' databases and their availability to the scientific community - a systematic review.

de Almeida Vieira Lima LM, Nunes NG, da Silva Dias PG, Marques FJ.

Curr Drug Saf. 2012 Apr;7(2):170-5. Review.

PMID:
22873501
13.

Decision support methods for the detection of adverse events in post-marketing data.

Hauben M, Bate A.

Drug Discov Today. 2009 Apr;14(7-8):343-57. doi: 10.1016/j.drudis.2008.12.012. Epub 2009 Jan 31. Review.

PMID:
19187799
14.

[Practical value of active prospective monitoring of drug therapy safety].

Ovchinnikova EA, Nazimkin KE, Iagudina RI.

Antibiot Khimioter. 2006;51(9-10):40-6. Review. Russian. No abstract available.

PMID:
18030790
15.

Informatic tools and approaches in postmarketing pharmacovigilance used by FDA.

Weaver J, Willy M, Avigan M.

AAPS J. 2008;10(1):35-41. doi: 10.1208/s12248-007-9004-5. Epub 2008 Jan 25. Review.

16.

New approaches to drug safety: a pharmacovigilance tool kit.

Wise L, Parkinson J, Raine J, Breckenridge A.

Nat Rev Drug Discov. 2009 Oct;8(10):779-82. doi: 10.1038/nrd3002. Epub 2009 Sep 18. Review.

PMID:
19763106
17.

A brief primer on automated signal detection.

Hauben M.

Ann Pharmacother. 2003 Jul-Aug;37(7-8):1117-23. Review.

PMID:
12841826
18.

Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture?

Coloma PM, Trifirò G, Patadia V, Sturkenboom M.

Drug Saf. 2013 Mar;36(3):183-97. doi: 10.1007/s40264-013-0018-x. Review.

PMID:
23377696
19.

[Drug safety: from development to clinical use].

Ovchinnikova EA, Gerasimov VB.

Antibiot Khimioter. 2006;51(6):15-22. Review. Russian. No abstract available.

PMID:
17523417
20.

Postmarketing surveillance of adverse drug reactions: patient self-monitoring.

Fisher S, Bryant SG.

J Am Board Fam Pract. 1992 Jan-Feb;5(1):17-25. Review.

PMID:
1561919

Supplemental Content

Support Center